KKR-led investor group makes additional investment in fungal biotech firm Sylvan

Sylvan’s existing investor Novo Holdings increased its ownership stake in the company as part of this round.

  • Founded in 1932, Sylvan operates multiple production facilities around the world and serves customers across 65 countries.
  • The investors that participated in this transaction include TPG NewQuest, China Post Insurance, Schroders Capital and Tsao Pao Chee

A KKR-led investor group has made an additional investment in Sylvan, a Pennsylvania-based fungal biotechnology company.

Share this